-
Je něco špatně v tomto záznamu ?
The effect of caffeine dose on caffeine and paraxanthine changes in serum and saliva and CYP1A2 enzyme activity in athletes: a randomized placebo-controlled crossover trial
N. Główka, J. Malik, J. Anioła, EE. Zawieja, A. Chmurzynska, K. Durkalec-Michalski
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 2004-12-01
BioMedCentral Open Access
od 2004
Directory of Open Access Journals
od 2004
Free Medical Journals
od 2004
PubMed Central
od 2004
Europe PubMed Central
od 2004
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2004-01-01
Open Access Digital Library
od 2004-08-01
Medline Complete (EBSCOhost)
od 2004-08-17
Nursing & Allied Health Database (ProQuest)
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2004
Springer Nature OA/Free Journals
od 2004-12-01
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Although caffeine (CAF) supplementation has been shown to improve exercise performance, its dose-dependent effect on CAF metabolism has not been sufficiently investigated. The aim of this study was to evaluate the effects of 3, 6 and 9 mg of CAF/kgBM on changes of CAF and paraxanthine (PRX) in the serum and saliva at four time-points. METHODS: In a randomized, double-blind, placebo-controlled crossover design, acute pre-exercise supplementation in 26 moderately-trained athletes, participating in high-intensity functional training (HIFT), was examined. The study protocol involved CAF/PRX biochemical analyses of serum and saliva with respect to CYP1A2 polymorphism and CYP1A2 enzyme activity. RESULTS: Despite significant differences between the serum and saliva levels of CAF and PRX, there was no difference in the PRX/CAF ratio. The interaction effect of dose and time-points for PRX concentration was revealed. The main effects of dose were observed for CAF and the PRX/CAF ratio. The main effect of time-points was registered only for serum CAF. CONCLUSIONS: Dose- and time-dependent effect of CAF supplementation on CAF and PRX in the serum and saliva of athletes was confirmed, but there was no effect of the CAF dose on CYP1A2 enzyme activity, nor was there an interaction of CYP1A2 with enzyme inducibility. The CAF/PRX correlation indicated the possibility of interchangeable use of serum and/or saliva analyses in exercise studies. CLINICAL TRIAL REGISTRATION: This trial was registered prospectively at ClinicalTrials.gov (NCT03822663, registration date: 30/01/2019).
Department of Human Nutrition and Dietetics Poznań University of Life Sciences Poznań Poland
Department of Pedagogy Poznan University of Physical Education Poznań Poland
Department of Sports Dietetics Poznan University of Physical Education Poznań 61 871 Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002165
- 003
- CZ-PrNML
- 005
- 20250123102009.0
- 007
- ta
- 008
- 250117s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12986-024-00863-3 $2 doi
- 035 __
- $a (PubMed)39529054
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Główka, Natalia $u Department of Sports Dietetics, Poznan University of Physical Education, Poznań, 61- 871, Poland. glowka@awf.poznan.pl
- 245 14
- $a The effect of caffeine dose on caffeine and paraxanthine changes in serum and saliva and CYP1A2 enzyme activity in athletes: a randomized placebo-controlled crossover trial / $c N. Główka, J. Malik, J. Anioła, EE. Zawieja, A. Chmurzynska, K. Durkalec-Michalski
- 520 9_
- $a BACKGROUND: Although caffeine (CAF) supplementation has been shown to improve exercise performance, its dose-dependent effect on CAF metabolism has not been sufficiently investigated. The aim of this study was to evaluate the effects of 3, 6 and 9 mg of CAF/kgBM on changes of CAF and paraxanthine (PRX) in the serum and saliva at four time-points. METHODS: In a randomized, double-blind, placebo-controlled crossover design, acute pre-exercise supplementation in 26 moderately-trained athletes, participating in high-intensity functional training (HIFT), was examined. The study protocol involved CAF/PRX biochemical analyses of serum and saliva with respect to CYP1A2 polymorphism and CYP1A2 enzyme activity. RESULTS: Despite significant differences between the serum and saliva levels of CAF and PRX, there was no difference in the PRX/CAF ratio. The interaction effect of dose and time-points for PRX concentration was revealed. The main effects of dose were observed for CAF and the PRX/CAF ratio. The main effect of time-points was registered only for serum CAF. CONCLUSIONS: Dose- and time-dependent effect of CAF supplementation on CAF and PRX in the serum and saliva of athletes was confirmed, but there was no effect of the CAF dose on CYP1A2 enzyme activity, nor was there an interaction of CYP1A2 with enzyme inducibility. The CAF/PRX correlation indicated the possibility of interchangeable use of serum and/or saliva analyses in exercise studies. CLINICAL TRIAL REGISTRATION: This trial was registered prospectively at ClinicalTrials.gov (NCT03822663, registration date: 30/01/2019).
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malik, Jakub $u Department of Pedagogy, Poznan University of Physical Education, Poznań, Poland
- 700 1_
- $a Anioła, Jacek $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
- 700 1_
- $a Zawieja, Emilia E $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
- 700 1_
- $a Chmurzynska, Agata $u Department of Human Nutrition and Dietetics, Poznań University of Life Sciences, Poznań, Poland
- 700 1_
- $a Durkalec-Michalski, Krzysztof $u Department of Sports Dietetics, Poznan University of Physical Education, Poznań, 61- 871, Poland. durkalec-michalski@awf.poznan.pl $u Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic. durkalec-michalski@awf.poznan.pl
- 773 0_
- $w MED00165928 $t Nutrition & metabolism $x 1743-7075 $g Roč. 21, č. 1 (2024), s. 90
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39529054 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250117 $b ABA008
- 991 __
- $a 20250123102003 $b ABA008
- 999 __
- $a ok $b bmc $g 2254492 $s 1238168
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 21 $c 1 $d 90 $e 20241111 $i 1743-7075 $m Nutrition & metabolism $n Nutr Metab (Lond) $x MED00165928
- LZP __
- $a Pubmed-20250117